Date: Friday 17th February 2017
Time: 12 noon
Venue: G006, ILAS Building
Presenter: Dr Carys Jones – Research Officer at the Centre for Health Economics and Medicines Evaluation (CHEME), Bangor University, UK.
Email: email@example.com Twitter: @CarysLJones
Carys holds a PhD in Health Economics from Bangor University, awarded in 2014. Her thesis explored quality of life measurement for family carers of people living with dementia. After completing her PhD, Carys has remained at CHEME and has worked on several research projects aligned to her primary research interests of dementia and aging. These projects have evaluated a range of interventions, including: a visual arts intervention, self-management groups for people living in the early stages of dementia, a telephone befriending scheme, and a behaviour change intervention to promote healthy ageing. A full list of Carys’ publications is available at http://cheme.bangor.ac.uk/CarysJonesBiography.php
Title: Valuing the economic benefits of an arts intervention: the Dementia and Imagination project
There is growing interest in the use of non-pharmacological interventions such as arts programmes for people with dementia and their carers, though these have a mixed evidence base. Evaluative techniques such as Social Return on Investment (SROI) analysis capture the broader economic impact of an intervention and may contribute towards the establishment of an evidence base for the funding of arts programmes. This presentation describes the use of SROI analysis in the Dementia and Imagination (D&I) study, a visual arts intervention for people with dementia.
D&I was delivered to 120+ people in the UK across three settings: the community, care homes and hospital assessment units. Each group consisted of 12 weekly sessions of an arts (viewing and making) intervention led by professional artists. Outcomes such as changes in well-being for participants, engagement with art and the community, and changes in staff attitudes towards dementia were included in the analysis.
While SROI offers an opportunity to include broader outcomes than the cost-effectiveness analysis approach traditionally used in health economics, the selection of financial proxies for subjective outcomes such as well-being can be controversial and it is good practice to provide transparency in the figures used for an SROI analysis. The SROI analysis of D&I will provide policymakers with an estimate of the social value generated by investing in a visual arts programme for people with dementia.